
Contig Bio is a research partner that provides AI and ML-based solutions for biotech, pharmaceutical, and academic organizations. They specialize in accelerating scientific discoveries through advanced data analysis in genomics, transcriptomics, proteomics, and peptide design. Their proprietary platforms, SWARSH-G and SWARSH-P, offer cutting-edge analytics for spatial transcriptomics, single-cell RNA sequencing, ATAC-seq, and peptide-based therapeutics design. Contig Bio emphasizes a "science first" philosophy, delivering actionable biological insights, tailored solutions, and expert scientific support with a focus on data security and cost-effectiveness. They aim to help organizations unlock the full potential of their complex biological data to drive innovation in precision medicine and drug discovery.

Contig Bio is a research partner that provides AI and ML-based solutions for biotech, pharmaceutical, and academic organizations. They specialize in accelerating scientific discoveries through advanced data analysis in genomics, transcriptomics, proteomics, and peptide design. Their proprietary platforms, SWARSH-G and SWARSH-P, offer cutting-edge analytics for spatial transcriptomics, single-cell RNA sequencing, ATAC-seq, and peptide-based therapeutics design. Contig Bio emphasizes a "science first" philosophy, delivering actionable biological insights, tailored solutions, and expert scientific support with a focus on data security and cost-effectiveness. They aim to help organizations unlock the full potential of their complex biological data to drive innovation in precision medicine and drug discovery.